4.8 Article

Improving CRISPR-Cas nuclease specificity using truncated guide RNAs

Journal

NATURE BIOTECHNOLOGY
Volume 32, Issue 3, Pages 279-284

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nbt.2808

Keywords

-

Funding

  1. National Institutes of Health (NIH) Director's Pioneer Award [DP1 GM105378]
  2. NIH [R01 GM088040, NIH P50 HG005550]
  3. Jim and Ann Orr Massachusetts General Hospital (MGH) Research Scholar Award
  4. US Army Research Laboratory
  5. US Army-Research Office [W911NF-11-2-0056]

Ask authors/readers for more resources

Clustered, regularly interspaced, short palindromic repeat (CRISPR) RNA-guided nucleases (RGNs) are highly efficient genome editing tools(1-3). CRISPR-associated 9 (Cas9) RGNs are directed to genomic loci by guide RNAs (gRNAs) containing 20 nucleotides that are complementary to a target DNA sequence. However, RGNs can induce mutations at sites that differ by as many as five nucleotides from the intended target(4-6). Here we report that truncated gRNAs, with shorter regions of target complementarity <20 nucleotides in length, can decrease undesired mutagenesis at some off-target sites by 5,000-fold or more without sacrificing on-target genome editing efficiencies. In addition, use of truncated gRNAs can further reduce off-target effects induced by pairs of Cas9 variants that nick DNA (paired nickases). Our results delineate a simple, effective strategy to improve the specificities of Cas9 nucleases or paired nickases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available